336
Views
6
CrossRef citations to date
0
Altmetric
Drug evaluation

Evaluating pharmacokinetics of bempedoic acid in the treatment of hypercholesterolemia

ORCID Icon, ORCID Icon &
Pages 1031-1038 | Received 28 Mar 2021, Accepted 30 Jun 2021, Published online: 15 Jul 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ramyashree Tummala, Manasvi Gupta, Arvind Reddy Devanabanda, Dhrubajyoti Bandyopadhyay, Wilbert S. Aronow, Kausik K. Ray, Mamas Mamas & Raktim K. Ghosh. (2022) Bempedoic acid and its role in contemporary management of hyperlipidemia in atherosclerosis. Annals of Medicine 54:1, pages 1287-1296.
Read now
Brian Tomlinson, Elaine Chow, Paul Chan & Christopher Wai Kei Lam. (2021) An evaluation of the pharmacokinetics of inclisiran in the treatment of atherosclerotic cardiovascular disease. Expert Opinion on Drug Metabolism & Toxicology 17:12, pages 1353-1361.
Read now

Articles from other publishers (4)

Gianni Biolo, Pierandrea Vinci, Alessandro Mangogna, Matteo Landolfo, Paolo Schincariol, Nicola Fiotti, Filippo Mearelli & Filippo Giorgio Di Girolamo. (2022) Mechanism of action and therapeutic use of bempedoic acid in atherosclerosis and metabolic syndrome. Frontiers in Cardiovascular Medicine 9.
Crossref
Federica Fogacci, Marina Giovannini, Elisa Grandi, Egidio Imbalzano, Daniela Degli Esposti, Claudio Borghi & Arrigo F. G. Cicero. (2022) Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients. Journal of Clinical Medicine 11:16, pages 4701.
Crossref
Asvitha Govindaraju & Sarvesh Sabarathinam. (2021) Bempedoic acid: A nonstatin drug for the management of hypercholesterolemia. Health Science Reports 4:4.
Crossref
Carlos Escobar, Vivencio Barrios, Albert Ariza, Raquel Campuzano, José María Gámez & José María Mostaza. (2021) Empleo del ácido bempedoico en los pacientes con dislipemia. Una aproximación práctica. Revista Española de Cardiología Suplementos 21, pages 1-7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.